Antimicrobial activities and membrane-active mechanism of CPF-C1 against multidrug-resistant bacteria, a novel antimicrobial peptide derived from skin secretions of the tetraploid frog Xenopus clivii

Journal of Peptide Science

Volumn 20, Issue 11, 2014, Pages 876-884

  Xie, Junqiu ^a   Gou, Yuanmei ^a   Zhao, Qian ^a   Wang, Kairong ^a   Yang, Xiongli ^a   Yan, Jiexi ^a   Zhang, Wei ^a   Zhang, Bangzhi ^a   Ma, Chi ^a   Wang, Rui ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Antimicrobial peptides; CPF C1; Membrane active action mode; Multidrug resistant bacteria

Indexed keywords

AMPICILLIN; CALCEIN; CEFAZOLIN; CPF C1; ERYTHROMYCIN; KANAMYCIN; LIPOSOME; POLYPEPTIDE ANTIBIOTIC AGENT; PROPIDIUM IODIDE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; BACTERIAL DNA; CPF-C1 PEPTIDE, XENOPUS CLIVII; XENOPUS PROTEIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM; CELL VACUOLE; CELL VIABILITY ASSAY; CONTROLLED STUDY; CYTOTOXICITY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; INNER MEMBRANE; MAMMAL CELL; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; OUTER MEMBRANE; SCANNING ELECTRON MICROSCOPY; SKIN SECRETION; TETRAPLOIDY; TRANSMISSION ELECTRON MICROSCOPY; XENOPUS; XENOPUS CLIVII; ACINETOBACTER BAUMANNII; AMINO ACID SEQUENCE; ANIMAL; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CHEMISTRY; DRUG EFFECTS; GENETICS; HEK293 CELL LINE; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MOLECULAR GENETICS; POLYPLOIDY; PSEUDOMONAS AERUGINOSA; SKIN; STAPHYLOCOCCUS AUREUS; ULTRASTRUCTURE;

ANURA; XENOPUS CLIVII;

ACINETOBACTER BAUMANNII; AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; HEK293 CELLS; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR SEQUENCE DATA; POLYPLOIDY; PSEUDOMONAS AERUGINOSA; SKIN; STAPHYLOCOCCUS AUREUS; XENOPUS; XENOPUS PROTEINS;

EID: 84915823825     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.2679     Document Type: Article

References (40)

1. Putty S, Rai A, Jamindar D, Pagano P, Quinn CL, Mima T, Schweizer HP, Gutheil WG. Characterization of D-boroAla as a novel broad-spectrum antibacterial agent targeting D-Ala-D-Ala ligase. Chem. Biol. Drug Des. 2011; 78: 757-763.
2. Read AF, Day T, Huijben S. The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy. Proc. Natl. Acad. Sci. U. S. A. 2011. DOI: 10.1073/pnas.1100299108.
3. Theresa B. Race against time to develop new antibiotics. Bull. World Health Organ. 2011; 89: 88-89. DOI: 10.2471/BLT.11.030211.
4. Wimley W, Hristova K. Antimicrobial peptides: successes, challenges and unanswered questions. J. Membr. Biol. 2011; 239: 27-34.
5. Hancock REW, Sahl HG. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 2006; 24: 1551-1557.
6. Hale JD, Hancock RE. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev. Anti Infect. Ther. 2007; 5: 951-959.
7. Guaní-Guerra E, Santos-Mendoza T, Lugo-Reyes SO, Terán LM. Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin. Immunol. 2010; 135: 1-11.
8. Albiol Matanic VC, Castilla V. Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus. Int. J. Antimicrob. Agents 2004; 23: 382-389.
9. Bulet P, Stöcklin R, Menin L. Antimicrobial peptides: from invertebrates to vertebrates. Immunol. Rev. 2004; 198: 169-184.
10. Yeaman MR, Yount NY. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 2003; 55: 27-55.
11. Oyston PC, Fox MA, Richards SJ, Clark GC. Novel peptide therapeutics for treatment of infections. J. Med. Microbiol. 2009; 58: 977-987.
12. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389-395.
13. Wang G, Li X, Wang Z. APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res. 2009; 37: D933-D937.
14. Conlon JM, Mechkarska M, Ahmed E, Leprince J, Vaudry H, Schweizer HP, Gutheil WG. Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae). Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2011; 153: 350-354.
15. Fields GB, Noble RL. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 1990; 35: 161-214.
16. Takemura H, Kaku M, Kohno S, Hirakata Y, Tanaka H, Yoshida R, Tomono K, Koga H, Wada A, Hirayama T, Kamihira S. Evaluation of susceptibility of gram-positive and -negative bacteria to human defensins by using radial diffusion assay. Antimicrob. Agents Chemother. 1996; 40: 2280-2284.
17. Yan J, Wang K, Dang W, Chen R, Xie J, Zhang B, Song J, Wang R. Two hits are better than one: membrane-active and DNA binding-related double-action mechanism of NK-18, a novel antimicrobial peptide derived from mammalian NK-Lysin. Antimicrob. Agents Chemother. 2013; 57: 220-228.
18. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard: Ninth Edition. M07-A9. CLSI: Wayne, PA. 2012.
19. Pag U, Oedenkoven M, Papo N, Oren Z, Shai Y, Sahl H-G. In vitro activity and mode of action of diastereomeric antimicrobial peptides against bacterial clinical isolates. J. Antimicrob. Chemother. 2004; 53: 230-239.
20. Qian CD, Wu XC, Teng Y, Zhao WP, Li O, Fang SG, Huang ZH, Gao HC. Battacin (Octapeptin B5), a new cyclic lipopeptide antibiotic from Paenibacillus tianmuensis active against multidrug-resistant Gram-negative bacteria. Antimicrob. Agents Chemother. 2012; 56: 1458-1465.
21. Wang B, Navath RS, Menjoge AR, Balakrishnan B, Bellair R, Dai H, Romero R, Kannan S, Kannan RM. Inhibition of bacterial growth and intramniotic infection in a guinea pig model of chorioamnionitis using PAMAM dendrimers. Int. J. Pharm. 2010; 395: 298-308.
22. Je JY, Kim SK. Chitosan derivatives killed bacteria by disrupting the outer and inner membrane. J. Agric. Food Chem. 2006; 54: 6629-6633.
23. Cheng JT, Hale JD, Elliot M, Hancock RE, Straus SK. Effect of membrane composition on antimicrobial peptides aurein 2.2 and 2.3 from Australian Southern bell frogs. Biophys. J. 2009; 96: 552-565.
24. Tang YL, Shi YH, Zhao W, Hao G, Le GW. Interaction of MDpep9, a novel antimicrobial peptide from Chinese traditional edible larvae of housefly, with Escherichia coli genomic DNA. Food Chem. 2009; 115: 867-872.
25. Loh B, Grant C, Hancock RE. Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 1984; 26: 546-551.
26. Silvestro L, Weiser JN, Axelsen PH. Antibacterial and antimembrane activities of Cecropin A in Escherichia coli. Antimicrob. Agents Chemother. 2000; 44: 602-607.
27. Fernebro J. Fighting bacterial infections-future treatment options. Drug Resist. Updat. 2011; 14: 125-139.
28. Reddy KVR, Yedery RD, Aranha C. Antimicrobial peptides: premises and promises. Int. J. Antimicrob. Agents 2004; 24: 536-547.
29. Teixeira V, Feio MJ, Bastos M. Role of lipids in the interaction of antimicrobial peptides with membranes. Prog. Lipid Res. 2012; 51: 149-177.
30. Owen RJ, Li J, Nation RL, Spelman D. In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates. J. Antimicrob. Chemother. 2007; 59: 473-477.
31. Hancock REW, Scott MG. The role of antimicrobial peptides in animal defenses. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 8856-8861.
32. Oren Z, Shai Y. Mode of action of linear amphipathic α-helical antimicrobial peptides. Biopolymers 1998; 47: 451-463.
33. Bandyopadhyay S, Lee M, Sivaraman J, Chatterjee C. Model membrane interaction and DNA-binding of antimicrobial peptide Lasioglossin II derived from bee venom. Biochem. Biophys. Res. Commun. 2013; 430: 1-6.
34. Ayyalusamy R, Sathiah T, Dong KL, Anmin T, Lee M. Mechanisms of solid-State NMR investigation of the membrane-disrupting mechanism of antimicrobial peptides MSI-78 and MSI-594 derived from Magainin 2 and Melittin. Biophys. J. 2006; 91: 206-216.
35. Katsumi M, Ken-ichi S, Mitsunori H, Nobutaka F, Koichiro M. Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria. Biochim. Biophys. Acta 1997; 1327: 119-130.
36. Nguyen LT, Haney EF, Vogel HJ. The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol. 2011; 29: 464-472.
37. Dong N, Ma Q, Shan A, Lv Y, Hu W, Gu Y, Li Y. Strand length-dependent antimicrobial activity and membrane-active mechanism of arginine- and valine-rich β-hairpin-like antimicrobial peptides. Antimicrob. Agents Chemother. 2012; 56: 2994-3003.
38. Wang K, Dang W, Yan J, Chen R, Liu X, Yan W, Zhang B, Xie J, Zhang J, Wang R. Membrane perturbation action mode and structure-activity relationships of protonectin, a novel antimicrobial peptide from the venom of the Neotropical Social Wasp Agelaia pallipes pallipes. Antimicrob. Agents Chemother. 2013; 57: 4632-4639.
39. Morita S, Tagai C, Shiraishi T, Miyaji K, Iwamuro S. Differential mode of antimicrobial actions of arginine-rich and lysine-rich histones against Gram-positive Staphylococcus aureus. Peptides 2013; 48: 75-82.
40. Fedders H, Podschun R, Leippe M. The antimicrobial peptide Ci-MAM-A24 is highly active against multidrug-resistant and anaerobic bacteria pathogenic for humans. Int. J. Antimicrob. Agents 2010; 36: 264-266.